ArticleInternational journal of clinical oncology2024

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval of nivolumab for unresectable advanced or recurrent epithelial skin malignancies in Japan.

Noriomi Matsumura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.